Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy

Breast Cancer Research and Treatment

Volumn 115, Issue 2, 2009, Pages 343-348

  Yang, Qifeng ^a,b   Moran, Meena S ^c   Haffty, Bruce G ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b SHANDONG UNIVERSITY   (China)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bcl 2; Breast cancer; Conservative surgery; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PARAFFIN; PROGESTERONE RECEPTOR; PROTEIN ANTIBODY; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67349249819     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0068-4     Document Type: Article

References (32)

1. B Fisher S Anderson J Bryant 2002 Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 16 1233 1241 10.1056/NEJMoa022152
2. B Fisher JH Jeong S Anderson J Bryant ER Fisher N Wolmark 2002 Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation N Engl J Med 347 8 567 575 10.1056/NEJMoa020128
3. A Luini G Gatti S Zurrida 2007 The evolution of the conservative approach to breast cancer Breast 16 2 120 129 10.1016/j.breast.2006.11.001
4. B Fisher S Anderson ER Fisher 1991 Significance of ipsilateral breast tumour recurrence after lumpectomy Lancet 338 8763 327 331 10.1016/0140-6736(91) 90475-5
5. BG Haffty D Carter SD Flynn 1993 Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting Int J Radiat Oncol Biol Phys 27 3 575 583
6. A Fourquet F Campana B Zafrani 1989 Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up Int J Radiat Oncol Biol Phys 17 4 719 725
7. JM Kurtz J Jacquemier R Amalric 1990 Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy Cancer 65 8 1867 1878 10.1002/1097-0142(19900415)65: 8<1867::AID-CNCR2820650833>3.0.CO;2-I
8. J Borger H Kemperman A Hart H Peterse J van Dongen H Bartelink 1994 Risk factors in breast-conservation therapy J Clin Oncol 12 4 653 660
9. SJ Schnitt JL Connolly JR Harris S Hellman RB Cohen 1984 Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy Cancer 53 5 1049 1057 10.1002/1097-0142(19840301)53: 5<1049::AID-CNCR2820530506>3.0.CO;2-O
10. BC Turner BG Haffty L Narayanan 1997 Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation Cancer Res 57 15 3079 3083
11. BG Haffty F Brown D Carter S Flynn 1996 Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: a case-control study Int J Radiat Oncol Biol Phys 35 4 751 757 10.1016/0360-3016(96)00150-2
12. BC Turner AA Gumbs D Carter PM Glazer BG Haffty 2000 Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation Int J Radiat Oncol Biol Phys 47 5 1169 1176 10.1016/S0360-3016(00)00525-3
13. A Recht MJ Houlihan 1995 Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. A review Ann Surg 222 1 9 18 10.1097/00000658-199507000-00003
14. L Zhou R Yuan L Serggio 2003 Molecular mechanisms of irradiation-induced apoptosis Front Biosci 8 d9 d19 10.2741/927
15. H Steller 1995 Mechanisms and genes of cellular suicide Science 267 5203 1445 1449 10.1126/science.7878463
16. CB Thompson 1995 Apoptosis in the pathogenesis and treatment of disease Science 267 5203 1456 1462 10.1126/science.7878464
17. CJ Hawkins DL Vaux 1994 Analysis of the role of bcl-2 in apoptosis Immunol Rev 142 127 139 10.1111/j.1600-065X.1994.tb00886.x
18. QF Yang T Sakurai G Yoshimura 2000 Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma Breast Cancer Res Treat 61 3 211 216 10.1023/A:1006474307180
19. Q Yang T Sakurai G Yoshimura 2003 Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy Oncol Rep 10 1 121 125
20. BG Haffty Q Yang M Reiss 2006 Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 36 5652 5657 10.1200/JCO.2006.06.5664
21. BG Haffty D Fischer JJ Fischer 1990 Regional nodal irradiation in the conservative treatment of breast cancer Int J Radiat Oncol Biol Phys 19 4 859 865
22. S Pejavar LD Wilson BG Haffty 2006 Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT) Int J Radiat Oncol Biol Phys 66 5 1320 1327 10.1016/j.ijrobp.2006.07.1379
23. A Jemal R Siegel E Ward 2006 Cancer statistics, 2006 CA Cancer J Clin 56 2 106 130
24. S Fulda KM Debatin 2006 Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy Oncogene 25 34 4798 4811 10.1038/sj.onc.1209608
25. LR Haith Jr ML Patton WT Goldman KM McCutchan 1993 Diminishing blood loss during operation for burns Surg Gynecol Obstet 176 2 119 123
26. JC Sabourin A Martin J Baruch JB Truc A Gompel P Poitout 1994 bcl-2 expression in normal breast tissue during the menstrual cycle Int J Cancer 59 1 1 6 10.1002/ijc.2910590102
27. TJ McDonnell N Deane FM Platt 1989 bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation Cell 57 1 79 88 10.1016/0092-8674(89)90174-8
28. TJ McDonnell SJ Korsmeyer 1991 Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18) Nature 349 6306 254 256 10.1038/349254a0
29. JA Pietenpol N Papadopoulos S Markowitz JK Willson KW Kinzler B Vogelstein 1994 Paradoxical inhibition of solid tumor cell growth by bcl2 Cancer Res 54 14 3714 3717
30. X Lin SR Denmeade JT Isaacs 1995 The genetics of programmed (apoptotic) cell death Cancer Surv 25 173 194
31. BA Rupnow SJ Knox 1999 The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy Apoptosis 4 2 115 143 10.1023/A:1009675028784
32. MG Daidone R Silvestrini A Luisi 1995 Changes in biological markers after primary chemotherapy for breast cancers Int J Cancer 61 3 301 305 10.1002/ijc.2910610304